Literature DB >> 30391429

Utilisation of dietary fibre (non-starch polysaccharide and resistant starch) molecules for diarrhoea therapy: A mini-review.

Xin Qi1, Richard F Tester2.   

Abstract

Within the last ten years the utilisation of dietary fibre formats (non-starch polysaccharide and resistant starch) for diarrhoea therapy, have been evaluated. These polysaccharides ferment within the colon and generate short chain fatty acids which facilitate sodium absorption. Comparisons between polysaccharide structure/physico-chemical properties and fermentation capacity in the large intestine are presented. The potential dichotomy associated with recommending dietary fibre ingestion to avoid and treat diarrhoea is also considered. Overall, this mini-review presents an overview of the current knowledge with respect to role of dietary fibre in the management (prevention and treatment) of diarrhoea (osmotic and secretory). It aims to inform the medical and non-medical communities with respect to this relatively poorly researched and understood health related area. Different forms of dietary fibre are considered in this context along with their mechanisms of action.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diarrhoea therapy; Dietary fibre; Polysaccharide

Mesh:

Substances:

Year:  2018        PMID: 30391429     DOI: 10.1016/j.ijbiomac.2018.10.195

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  2 in total

1.  Inhibitory Effect of Fermented Flammulina velutipes Polysaccharides on Mice Intestinal Inflammation.

Authors:  Sheng Ma; Jianxiong Xu; Ting Lai; Weina Xu; Jing Zhang; Hongcai Zhang; Weiyi Zhang
Journal:  Front Nutr       Date:  2022-06-21

2.  Contribution of fruit, vegetables, whole cereals, and legumes to total fibre intake in adult Croatian Dalmatian population.

Authors:  Marijana Matek Sarić; Marija Ljubičić; Ivana Lapčić; Raquel Pinho Ferreira Guiné
Journal:  Arh Hig Rada Toksikol       Date:  2020-06-29       Impact factor: 2.078

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.